Glenmark has received permission from the Food and Drug Administration for Tacrolimus Ointment, 0.03%, the generic of Leo Pharma's Protopic. Protopic Ointment, both 0.03% and 0.1% for adults, and only ...

Perrigo announced the availability of Tacrolimus Ointment, the generic version of Astellas’ Protopic Ointment. Protopic is an immunomodulator that is indicated as second-line therapy for short-term ...

Jan. 19, 2006 — The US Food and Drug Administration (FDA) has approved revisions to the safety labeling for 1% pimecrolimus cream ( Elidel, made by Novartis Pharmaceuticals Corporation) and tacrolimus ...

Glenmark Pharmaceuticals Limited, a research‐led, integrated, global pharmaceutical company has received final approval by the United States Food & Drug Administration (U.S. FDA) Tacrolimus Ointment, ...

Glenmark's Tacrolimus ointment, 0.03 per cent, will be distributed in the US by Glenmark Pharmaceuticals Inc, USA, it added. The Protopic Ointment, 0.03 per cent market (brand and all available ...

March 11, 2005 -- The U.S. Food and Drug Administration (FDA) has warned healthcare professionals and patients via public health advisory of the potential cancer risk associated with use of ...

-- Ointment (Tacrolimus Monohydrate) in a New Twice-Weekly Regimen can Help Prevent Eczema Flares Today sees the European launch of the first topical calcineurin inhibitor to be approved for the ...

WASHINGTON – The labels on two prescription creams to treat eczema will have to bear "black box" warnings of possible cancer risks. The Food and Drug Administration action Thursday follows an agency ...

Mumbai: Glenmark Pharmaceuticals Ltd., a pharmaceutical firm, has obtained final endorsement from the United States Food and Drug Administration (USFDA) for its Tacrolimus ointment, 0.03 per cent.

The labels on two prescription creams to treat eczema will have to bear “black box” warnings of possible cancer risks. The Food and Drug Administration action on Thursday follows an agency advisory ...